Incyte Corp financial data

Symbol
INCY on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
1801 Augustine Cut Off, Wilmington, DE
State of incorporation
DE
Fiscal year end
December 31
Former names
INCYTE INC (to 3/28/2003), INCYTE GENOMICS INC (to 2/25/2003), INCYTE PHARMACEUTICALS INC (to 4/18/2000)
Latest financial report
10-K - Q4 2024 - Feb 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 229 % -40.5%
Quick Ratio 5 % +13.9%
Debt-to-equity 48.3 % +59.4%
Return On Equity 0.87 % -93%
Return On Assets 0.59 % -93.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 194M shares -13.8%
Common Stock, Shares, Outstanding 193M shares -13.8%
Entity Public Float 9.9B USD -15.4%
Common Stock, Value, Issued 193K USD -13.8%
Weighted Average Number of Shares Outstanding, Basic 207M shares -7.39%
Weighted Average Number of Shares Outstanding, Diluted 211M shares -6.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.24B USD +14.8%
Cost of Revenue 312M USD +22.4%
Research and Development Expense 2.61B USD +60.2%
Costs and Expenses 4.18B USD +35.9%
Operating Income (Loss) 61.4M USD -90.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 317M USD -62%
Income Tax Expense (Benefit) 284M USD +20%
Net Income (Loss) Attributable to Parent 32.6M USD -94.5%
Earnings Per Share, Basic 0.16 USD/shares -94%
Earnings Per Share, Diluted 0.15 USD/shares -94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.69B USD -47.5%
Inventory, Net 58.9M USD -6.51%
Assets, Current 3.24B USD -30.3%
Deferred Income Tax Assets, Net 762M USD +20.6%
Property, Plant and Equipment, Net 763M USD +1.58%
Goodwill 156M USD 0%
Other Assets, Noncurrent 10.8M USD -79.2%
Assets 5.44B USD -19.7%
Accounts Payable, Current 197M USD +80.2%
Employee-related Liabilities, Current 189M USD +23%
Accrued Liabilities, Current 1.21B USD +29.6%
Liabilities, Current 1.64B USD +32.4%
Operating Lease, Liability, Noncurrent 16.8M USD +17.6%
Other Liabilities, Noncurrent 168M USD +12.3%
Liabilities 2B USD +25.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -13.1M USD -200%
Retained Earnings (Accumulated Deficit) -1.07B USD -769%
Stockholders' Equity Attributable to Parent 3.45B USD -33.6%
Liabilities and Equity 5.44B USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 219M USD
Net Cash Provided by (Used in) Financing Activities -12.4M USD -410%
Net Cash Provided by (Used in) Investing Activities -73.1M USD -156%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 193M shares -13.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.69B USD -47.5%
Deferred Tax Assets, Valuation Allowance 2.14B USD +2.07%
Deferred Tax Assets, Gross 2.94B USD +6.19%
Operating Lease, Liability 22.4M USD +12%
Payments to Acquire Property, Plant, and Equipment 48.7M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6.39M USD -98.9%
Lessee, Operating Lease, Liability, to be Paid 25.3M USD +11.7%
Property, Plant and Equipment, Gross 1.09B USD +6.85%
Operating Lease, Liability, Current 5.58M USD -1.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6M USD +75.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.87M USD +5.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.91M USD +8.94%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.51M USD +90.6%
Deferred Tax Assets, Operating Loss Carryforwards 316M USD -3.21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 87.7M USD +26.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.47M USD -15.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 21.9M USD +14.2%
Deferred Tax Assets, Net of Valuation Allowance 800M USD +19%
Share-based Payment Arrangement, Expense 266M USD +23.3%
Interest Expense 2.51M USD +2.32%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%